V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220006238 | 220002414 | 1.7 | null | Curative (C) | 2014-12-31 | 2014-12-31 | AML 19 TRIAL | N | N | 220029889 | AML19 TRIAL |
| 220006239 | 220002415 | null | 8.4 | Curative (C) | 2016-06-03 | 2016-06-03 | null | N | N | 220029895 | NOT MATCHED |
| 220006240 | 220002416 | 0 | null | Disease modification (D) | null | 2013-06-08 | Nilotinib | 2 | N | 220029897 | NILOTINIB |
| 220006241 | 220011366 | null | 0 | null | 2018-05-26 | 2018-05-27 | Nilotinib | null | null | 220029900 | NILOTINIB |
| 220006242 | 220002417 | null | 108.7 | Disease modification (D) | 2014-10-07 | 2014-11-06 | Nilotinib | N | N | 220029901 | NILOTINIB |
| 220006243 | 220002417 | null | 33.9 | Curative (C) | 2017-05-23 | 2017-05-23 | AML Relapsed FLA - Idarubicin | N | N | 220029901 | NOT MATCHED |
| 220006244 | 220016108 | 0 | 0 | Curative (C) | 2013-09-26 | 2013-09-26 | Nilotinib | 02 | N | 220029906 | NILOTINIB |
| 220006245 | 220002418 | 1.68 | 58.5 | Curative (C) | 2017-03-13 | 2017-03-14 | FLAG + Idarubicin | 2 | N | 220029907 | FLAG + IDARUBICIN |
| 220006246 | 220011368 | 1.72 | 76 | Curative (C) | 2017-12-07 | 2017-12-11 | Amsacrine + ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT) + BUSULFAN + CYTARABINE + FLUDARABINE | null | null | 220029909 | NOT MATCHED |
| 220006247 | 220011368 | null | 46.9 | Disease modification (D) | 2017-12-07 | 2017-12-07 | Nilotinib | N | N | 220029909 | NILOTINIB |
| 220006248 | 220002419 | null | 12.2 | Curative (C) | 2013-07-11 | 2013-07-11 | DAUNORUBICIN + METHOTREXATE + RITUXIMAB + VINCRISTINE | N | N | 220029913 | NOT MATCHED |
| 220006249 | 220002419 | 1.71 | 81 | Curative (C) | 2013-11-13 | 2013-11-21 | AML 19 TRIAL | 01 | N | 220029913 | AML19 TRIAL |
| 220006250 | 220002419 | 0 | 0 | Disease modification (D) | 2013-10-14 | 2013-10-24 | Nilotinib | N | N | 220029913 | NILOTINIB |
| 220006251 | 220002420 | 1.73 | 76.1 | null | 2017-06-25 | 2017-06-25 | FLAG + Idarubicin | 2 | N | 220029926 | FLAG + IDARUBICIN |
| 220006255 | 220002422 | null | null | Curative (C) | 2015-10-16 | 2015-10-16 | FLAG + Idarubicin | Y | null | 220029935 | FLAG + IDARUBICIN |
| 220006256 | 220002422 | 1.74 | 111 | null | 2013-10-20 | 2013-10-23 | Nilotinib | 2 | N | 220029935 | NILOTINIB |
| 220006257 | 220002422 | 1.97 | 73 | Curative (C) | null | 2013-11-13 | FLAG + Idarubicin | 2 | N | 220029935 | FLAG + IDARUBICIN |
| 220006258 | 220002422 | 1.6 | 90 | Curative (C) | 2014-02-16 | 2014-02-19 | AML Interim Guidelines FLAG-Ida | N | N | 220029935 | FLAG + IDARUBICIN |
| 220006259 | 220002422 | 0 | null | Curative (C) | null | 2017-12-08 | Nilotinib | 02 | N | 220029935 | NILOTINIB |
| 220006260 | 220002423 | null | 0 | null | null | 2014-05-21 | Nilotinib | N | N | 220029945 | NILOTINIB |
| 220006261 | 220002423 | 1.63 | 75.6 | Curative (C) | 2016-11-30 | 2016-11-30 | AML 19 TRIAL | Y | N | 220029945 | AML19 TRIAL |
| 220006262 | 220002423 | null | 70.2 | Curative (C) | 2014-07-20 | 2014-07-21 | AML MyeChild 01 A Mitozantrone/Cytarabine + GO | N | N | 220029945 | NOT MATCHED |
| 220006263 | 220002424 | 0 | 42 | Palliative (P) | 2013-07-18 | 2013-07-18 | AML Interim Guidelines | 1 | N | 220029951 | NOT MATCHED |
| 220006264 | 220002424 | null | 8 | Curative (C) | 2014-09-10 | 2014-09-16 | null | N | N | 220029951 | NOT MATCHED |
| 220006265 | 220002424 | 1.77 | 61.8 | Curative (C) | 2014-11-27 | 2014-11-28 | AML 19 TRIAL | N | N | 220029951 | AML19 TRIAL |
| 220006266 | 220002425 | null | null | Curative (C) | 2016-12-12 | 2016-12-13 | AML 19 TRIAL | Y | null | 220029955 | AML19 TRIAL |
| 220006267 | 220002426 | 1.66 | 95.1 | Curative (C) | 2013-05-12 | 2013-05-12 | AML 19 TRIAL | Y | null | 220029956 | AML19 TRIAL |
| 220006268 | 220002427 | 0 | null | Curative (C) | 2014-12-03 | 2014-12-03 | Nilotinib | 2 | N | 220029957 | NILOTINIB |
| 220006269 | 220002427 | 1.63 | 88.6 | Curative (C) | 2014-12-17 | 2014-12-17 | FLAG + Idarubicin | null | null | 220029957 | FLAG + IDARUBICIN |
| 220006270 | 220002427 | null | 0 | Palliative (P) | 2015-04-03 | 2015-04-04 | Nilotinib | 02 | null | 220029957 | NILOTINIB |
| 220006271 | 220002428 | 1.52 | 118 | Curative (C) | 2014-06-10 | 2014-06-12 | AML 19 TRIAL | null | null | 220029966 | AML19 TRIAL |
| 220006272 | 220011375 | 1.71 | 80 | Curative (C) | 2013-10-22 | 2013-10-23 | AML 19 TRIAL | 1 | N | 220029968 | AML19 TRIAL |
| 220006273 | 220002429 | 1.73 | 118 | Curative (C) | 2015-09-29 | 2015-09-29 | AML 19 TRIAL | 1 | N | 220029972 | AML19 TRIAL |
| 220006274 | 220002429 | 1.56 | 7 | Curative (C) | 2015-07-26 | 2015-08-10 | null | 02 | N | 220029972 | NOT MATCHED |
| 220006275 | 220002429 | 1.66 | 0 | Curative (C) | null | 2015-07-26 | FLAG + Idarubicin | 2 | N | 220029972 | FLAG + IDARUBICIN |
| 220006276 | 220002429 | null | 0 | Curative (C) | 2014-04-23 | 2015-05-24 | Nilotinib | N | N | 220029972 | NILOTINIB |
| 220006277 | 220002429 | 1.61 | 92.6 | Curative (C) | 2013-07-26 | 2013-07-26 | AML 19 TRIAL | 01 | null | 220029972 | AML19 TRIAL |
| 220006278 | 220002429 | 1.84 | 90.1 | Curative (C) | 2013-02-27 | 2013-03-03 | AML 19 TRIAL | Y | N | 220029972 | AML19 TRIAL |
| 220006279 | 220021729 | null | 0 | Curative (C) | 2015-12-10 | 2015-12-10 | Nilotinib | 02 | N | 220029983 | NILOTINIB |
| 220006280 | 220021729 | 1.7 | 76.4 | Curative (C) | 2015-08-09 | 2015-08-10 | AML 19 TRIAL | 01 | null | 220029983 | AML19 TRIAL |
| 220006282 | 220011377 | null | null | Curative (C) | null | 2014-05-01 | null | Y | N | 220029989 | NOT MATCHED |
| 220006283 | 220011377 | 1.78 | 98.2 | null | 2018-09-06 | 2018-09-07 | FLAG + Idarubicin | N | N | 220029989 | FLAG + IDARUBICIN |
| 220006284 | 220011377 | 0 | 0 | Disease modification (D) | 2014-12-18 | 2014-12-18 | Nilotinib | N | N | 220029989 | NILOTINIB |
| 220006285 | 220002431 | null | 0 | Curative (C) | 2015-05-21 | 2015-05-21 | Nilotinib | null | null | 220029995 | NILOTINIB |
| 220006286 | 220002432 | 1.67 | 76.4 | Curative (C) | 2017-04-26 | 2017-04-26 | AML 19 TRIAL | N | Y | 220029996 | AML19 TRIAL |
| 220006287 | 220002433 | null | 85.9 | Curative (C) | 2015-12-29 | 2016-01-01 | null | N | N | 220029997 | NOT MATCHED |
| 220006288 | 220002433 | null | 14.2 | Palliative (P) | 2016-10-20 | 2016-10-20 | AML Interim Guidelines FLA | 2 | N | 220029997 | NOT MATCHED |
| 220006289 | 220002434 | null | 115.9 | Curative (C) | 2013-01-12 | 2013-01-12 | AML 19 TRIAL | 01 | Y | 220030001 | AML19 TRIAL |
| 220006290 | 220002435 | 1.64 | null | Adjuvant (A) | 2016-09-02 | 2016-09-04 | Nilotinib | N | N | 220030002 | NILOTINIB |
| 220006291 | 220002436 | null | null | Curative (C) | 2017-06-07 | 2017-06-07 | Nilotinib | N | N | 220030003 | NILOTINIB |